Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer
- Status
- COMPLETED
- Phase
- NA
Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Phase III Trial to Compare the Efficacy, Safety and Pharmacokinetics of HD201 to Herceptin® in HER2+ Early Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE3
PHASE III RANDOMISED TRIAL to EVALUATE FOLFOX with or WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY for LOCALLY ADVANCED or METASTATIC OESOPHAGO-GASTRIC CARCINOMA
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients
- Status
- UNKNOWN
- Phase
- PHASE3
To Observe the Efficacy and Safety by Comparing Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With Radical Resection Versus Chemotherapy Alone in Advanced Gastric Cancer With Single Non-curable Factor.
- Status
- UNKNOWN
- Phase
- N/A
A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE3
Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel and Carboplatin for Patients With mCRPC and DNA-Repair Deficiencies
- Status
- TERMINATED
- Phase
- PHASE2
Definitive Concurrent Chemoradiotherapy With Docetaxel Plus Cisplatin Versus 5-fluorouracil Plus Cisplatin in Patients With Esophageal Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE3
Multicentric Randomised Trial for Resectable Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Trial of Dose Escalated BGB324 in Previously Treated Non-small Cell Lung Cancer.
- Status
- COMPLETED
- Phase
- PHASE1
A Study of RGX-104 in Patients With Advanced Lung & Endometrial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors
- Status
- COMPLETED
- Phase
- PHASE1